Diabetic Nephropathies
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease [Phase 4]
A Phase 4 clinical trial evaluating sympathetic nervous system inhibition for diabetic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating copeptin in adolescent participants with type 1 diabetes and early renal hemodynamic changes has compl…
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy [Phase 2]
Phase 2 trial evaluating safety and efficacy of different oral doses of BAY94-8862 in subjects with type 2 diabetes and diabetic nephropathy…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease [Phase 2, Phase 3]
Clinical trial update on adjuvant astragalus therapy for diabetic kidney disease across Phase 2 and Phase 3 evaluating efficacy, safety, and…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes [Phase 3]
Phase 3 multicenter trial investigating allopurinol to prevent kidney function loss in type 1 diabetes has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy [Phase 2, Phase 3]
Phase 2/3 clinical trial exploring N-acetylcysteine (NAC) for ameliorating diabetes-induced nephropathy; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Renoprotective Effects of Dapagliflozin in Type 2 Diabetes [Phase 4]
Phase 4 trial update evaluating renoprotective effects of dapagliflozin in type 2 diabetes; completed with posted results.